Iran Pharmis proudly participated in the Vascular Surgeons Midterm Congress, held on October 18-19, 2023, at the Rasht Conference Center. This prominent event provided a valuable platform for sharing knowledge, exchanging experiences, and discussing the latest challenges and opportunities in vascular surgery.

Iran Pharmis: Driving Innovation and Collaboration

Our expert team actively engaged in multiple panels and lectures, sharing insights and experiences with leading specialists in vascular surgery. These discussions offered critical opportunities to explore innovative solutions and future trends in the field.

Key Highlights of Iran Pharmis' Participation:

• Active involvement in expert panels, sharing industry knowledge.
• Establishing professional connections with top vascular surgeons.
• Gaining insights into current challenges and future opportunities in vascular surgery.

Showcasing Products and Strengthening Brand Presence

Iran Pharmis leveraged this opportunity to introduce its latest vascular surgery products and innovative solutions. Our booth served as an interactive space for engaging with healthcare professionals, exploring future collaborations, and reinforcing our market presence.

Booth Features:

• Presentation of specialized vascular surgery products.
• Direct interaction with specialists, addressing their inquiries.
• Receiving positive feedback and valuable suggestions.

Positive Outcomes for Iran Pharmis:

1.    Positive Participant Feedback:
The active product showcase and panel participation were well-received by attendees.

2.    Expanded Professional Network:
Strengthened relationships with top vascular surgery experts.

3.    Enhanced Brand Positioning:
Solidified Iran Pharmis as a leading provider of vascular surgery solutions in Iran.

Iran Pharmis: Committed to Innovation and Healthcare Advancement

Iran Pharmis remains dedicated to advancing healthcare by delivering cutting-edge medical equipment and fostering collaboration with industry professionals. Our presence at this congress highlighted our ongoing commitment to improving vascular surgery outcomes through innovation and partnership.